Abeona Therapeutics
ABEO
42 hedge funds and large institutions have $21.3M invested in Abeona Therapeutics in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 3
599% more call options, than puts
Call options by funds: $538K | Put options by funds: $77K
250% more funds holding
Funds holding: 12 → 42 (+30)
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
61% more capital invested
Capital invested by funds: $13.2M → $21.3M (+$8.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$6.89M |
| 2 |
SFM
Soros Fund Management
New York
|
+$4.01M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.65M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.44M |
| 5 |
Morgan Stanley
New York
|
+$720K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.69M |
| 2 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$4.24M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.77M |
| 4 |
DM
Deerfield Management
New York
|
-$1.1M |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$1K |
ABEO Hedge Fund Activity: Q2 2015 in Review
42 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q2 2015, worth a combined $21.3M — up 61% from $13.2M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ABEO positions and 3 closed out — a net gain of 30 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Knoll Capital Management, adding an estimated $6.89M. The largest seller was Perceptive Advisors, cutting an estimated $4.69M.
- 42 institutional investors held Abeona Therapeutics (ABEO) as of Q2 2015, up from 12 in Q1 2015.
- Funds reported $21.3M of Abeona Therapeutics stock for Q2 2015, up 61% quarter-over-quarter.
- 33 funds opened new Abeona Therapeutics positions in Q2 2015 and 3 closed out, a net change of +30 holders.
- The largest Abeona Therapeutics buyer in Q2 2015 was Knoll Capital Management, an estimated $6.89M added.
- The largest Abeona Therapeutics seller in Q2 2015 was Perceptive Advisors, an estimated $4.69M sold.
Based on aggregated 13F filings for Q2 2015.